EUVIMEDEUVIMED entdecken
Kohortenstudie

Risk of fracture among patients with rheumatoid arthritis according to serological status: a population-based retrospective cohort study

Seonghye Kim, Kyung-Do Han, Jinhyung Jung, Hyeonjin Cho, Seonyoung Kang, Hyungjin Kim, In Young Cho, Dong Wook Shin

Osteoporosis International · 2026

DOI: 10.1007/s00198-026-08028-z ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Osteoporosis International, 2026. Verfasst von Seonghye Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Family Medicine & Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Osteoporotic Fractures. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with rheumatoid arthritis have higher fracture risks than those without RA, particularly in seropositive cases. The risk of fractures remained elevated regardless of bDMARD or tsDMARD use, warranting further large-scale studies. Our findings highlight the need for active surveillance and timely intervention in RA patients, particularly those with SPRA and regardless of bDMARD or tsDMARD use. OBJECTIVES: Evidence of the association between the serological status and the risk of fracture among patients with rheumatoid arthritis (RA) considering exposure to disease-modifying antirheumatic drugs (DMARDs) is scarce. We investigated the risk of fracture among patients with RA according to the serological status considering exposures to biologic DMARDs (bDMARDs) or targeted synthetic DMARDs (tsDMARDs). METHODS: We conducted a population-based retrospective cohort study using the Korean National Health Insurance Service database including patients who were diagnosed with RA between 2010 and 2017 (n = 43,677) and controls matched according to age and sex (n = 131,031). RESULTS: Patients with RA had a higher risk of any fractures compared to matched controls (adjusted hazard ratio [aHR] 1.68, 95% confidence interval [CI] 1.62‒1.75). Patients with seropositive RA (SPRA) had an increased risk of fracture (aHR 1.19, 95% CI 1.11‒1.28 for any fractures; aHR 1.40, 95% CI 1.26‒1.55 for vertebral fractures; aHR 1.55, 95% CI 1.19‒2.02 for hip fractures) compared to those with seronegative RA. Compared to matched controls, RA patients showed higher fracture risk regardless of bDMARDs (exposed: 2.28-fold; unexposed: 1.64-fold) or tsDMARDs (exposed: 1.91-fold; unexposed: 1.68-fold). CONCLUSION: Patients with RA were at higher risk of fractures compared to those without RA, with even higher risk among those with SPRA. The risk of fractures remained elevated regardless of bDMARD or tsDMARD use, warranting further studies to explore the impact of bDMARDs and tsDMARDs on fracture risk in patients with RA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidOsteoporotic FracturesHumansFemaleRetrospective StudiesMaleMiddle AgedAntirheumatic AgentsAgedRisk AssessmentRepublic of KoreaAdultDatabases, FactualBiological Products

Stichwörter der Autor:innen

Disease-modifying antirheumatic drugFractureRheumatoid arthritisSeronegativeSeropositive

Substanzen

Antirheumatic AgentsBiological Products

Autor:innen und Institutionen

  • Department of Family Medicine & Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
  • Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
  • Department of Digital Health, Samsung Advanced Institute of Health Science and Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea.
  • Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Medical Humanities, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Zitieren

APA

Kim, S., Han, K. D., Jung, J., Cho, H., Kang, S., Kim, H., Cho, I. Y., & Shin, D. W. (2026). Risk of fracture among patients with rheumatoid arthritis according to serological status: a population-based retrospective cohort study. Osteoporosis International. https://doi.org/10.1007/s00198-026-08028-z

Vancouver

Kim S, Han KD, Jung J, Cho H, Kang S, Kim H, et al. Risk of fracture among patients with rheumatoid arthritis according to serological status: a population-based retrospective cohort study. Osteoporosis International. 2026. doi:10.1007/s00198-026-08028-z

BibTeX
@article{Kim2026,
  author = {Kim, Seonghye and Han, Kyung-Do and Jung, Jinhyung and Cho, Hyeonjin and Kang, Seonyoung and Kim, Hyungjin and Cho, In Young and Shin, Dong Wook},
  title = {Risk of fracture among patients with rheumatoid arthritis according to serological status: a population-based retrospective cohort study},
  journal = {Osteoporosis International},
  year = {2026},
  doi = {10.1007/s00198-026-08028-z}
}
Kostenlos starten →